Treatment begins after an asynchronous online intake reviewed by a provider, usually within 24 hours
Compounded semaglutide products by Noom are not FDA approved and not offered in every US state
Evidence remains limited and inconclusive, and these medications are not approved for substance use disorders
Visiteuse, visiteur, bonjour
BMI, body mass index: CVD, cardiovascular disease
Omzo's own Terms explicitly state the platform "makes no claims that its compounded formulations are equivalent to, have the same active ingredient as, or will produce the same clinical outcomes as FDA-approved drugs." The active ingredient overlaps